产品名称
抗淀粉样蛋白前体蛋白，C-末端（751-770）兔pAb, liquid, Calbiochem®
biological source
rabbit
antibody form
serum
antibody product type
primary antibodies
clone
polyclonal
form
liquid
species reactivity
human
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
dilution
(Immunoblotting (1:5000-1:20,000)
Immunofluorescence (1:1000)
Immunohistochemistry (1:1000)
Immunoprecipitation (1:1000))
isotype
IgG
shipped in
ambient
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
Immunogen
人
合成肽[(C)KMQQNGYENPTYKFFEQMQN]，对应于人前体蛋白（APP）的751-770位氨基酸，与KLH偶联
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
采购本材料仅供研究使用。在将0433抗体或任何衍生物用于临床诊断或治疗目的之前，请用户向Mayo索取许可证。有关许可信息，请联系：Mayo Medical Ventures，技术商业化办公室（507）284-8878，200 First Street SW，Rochester，MN 55905-001。
Other Notes
Pinnix, I., et al. 2001.J. Biol. Chem.276, 481.
合适的工作稀释度由与测定条件相关的变量决定。
Preparation Note
初次融化后，等分并冷冻（-20°C）。
Application
免疫印迹（1:5000-1:20,000）
免疫荧光（1:1000）
免疫组织化学（1:1000）
免疫沉淀（1:1000）
免疫荧光（1:1000）
免疫组织化学（1:1000）
免疫沉淀（1:1000）
Disclaimer
毒性：标准处理（A）
General description
兔多克隆抗体以未稀释的血清形式提供。识别全长APP和C端可溶性产物CTFγ（~6 kDa）、CTFα（~9 kDa）和CTFβ（~11 kDa）。
兔多克隆抗淀粉样蛋白前体蛋白C末端（751-770）可识别全长APP和C末端可溶性产物CTFα，β和γ。经验证可用于WB、IF、IHC和IP。
识别全长APP和C端可溶性产物CTFγ（~6 kDa）、CTFα（~9 kDa）和CTFβ（~11 kDa）。抗体靶基因符号：APP 靶标异名：AAA，AD1，Adap，AL024401，淀粉样蛋白前体，淀粉样蛋白糖蛋白，APP异构体1，APPI，appican，CTFgamma，CVAP，E030013M08RIK，Nexin II，P3，PN2，PreA4，蛋白酶 NEXIN2 Entrez基因名称：淀粉样β（A4）前体蛋白 Hu Entrez ID：351（相关抗体：PC729, PC152,PC151, PC150, PC149, NE1012,171609, 171608, 171607, 171606, 171605, 171604, 171603, 171598, 171537) Mu Entrez ID: 11820 大鼠Entrez ID：54226
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Vincent J Mecozzi et al.
Nature chemical biology, 10(6), 443-449 (2014-04-22)
Retromer is a multiprotein complex that trafficks cargo out of endosomes. The neuronal retromer traffics the amyloid-precursor protein (APP) away from endosomes, a site where APP is cleaved into pathogenic fragments in Alzheimer's disease. Here we determined whether pharmacological chaperones
Yang Xiang et al.
Acta neuropathologica, 130(4), 487-499 (2015-09-14)
Amyloid-beta (Aβ) plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). The physiological capacity of peripheral tissues and organs in clearing brain-derived Aβ and its therapeutic potential for AD remains largely unknown. Here, we measured blood Aβ levels
Dario Tejera et al.
The EMBO journal, 38(17), e101064-e101064 (2019-07-31)
Alzheimer's disease is the most prevalent type of dementia and is caused by the deposition of extracellular amyloid-beta and abnormal tau phosphorylation. Neuroinflammation has emerged as an additional pathological component. Microglia, representing the brain's major innate immune cells, play an
Jenna C Carroll et al.
Brain research, 1366, 233-245 (2010-10-12)
The risk of Alzheimer's disease (AD) is higher in women than in men, a sex difference that likely results from the effects of sex steroid hormones. To investigate this relationship, we first compared progression of β-amyloid (Aβ) pathology in male
Giselle P Lim et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 25(12), 3032-3040 (2005-03-25)
Epidemiological studies suggest that increased intake of the omega-3 (n-3) polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA) is associated with reduced risk of Alzheimer's disease (AD). DHA levels are lower in serum and brains of AD patients, which could result
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持